Robinson James A. Jr. bought URGN
June 22, 2026 · Form 4 insider transaction
Robinson James A. Jr. bought 8,000 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderRobinson James A. Jr.
RoleDirector
CompanyUroGen Pharma Ltd. (URGN)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after8,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.; The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.